Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
Articolo
Data di Pubblicazione:
2016
Citazione:
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial / Watz, Henrik; Tetzlaff, Kay; Wouters, Emiel F. M; Kirsten, Anne; Magnussen, Helgo; Rodriguez Roisin, Roberto; Vogelmeier, Claus; Fabbri, Leonardo; Chanez, Pascal; Dahl, Ronald; Disse, Bernd; Finnigan, Helen; Calverley, Peter M. A.. - In: THE LANCET RESPIRATORY MEDICINE. - ISSN 2213-2600. - 4:5(2016), pp. 390-398. [10.1016/S2213-2600(16)00100-4]
Abstract:
Blood eosinophil counts might predict response to inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) and a history of exacerbations. We used data from the WISDOM trial to assess whether patients with COPD with higher blood eosinophil counts would be more likely to have exacerbations if ICS treatment was withdrawn.
Tipologia CRIS:
Articolo su rivista
Elenco autori:
Watz, Henrik; Tetzlaff, Kay; Wouters, Emiel F. M; Kirsten, Anne; Magnussen, Helgo; Rodriguez Roisin, Roberto; Vogelmeier, Claus; Fabbri, Leonardo; Chanez, Pascal; Dahl, Ronald; Disse, Bernd; Finnigan, Helen; Calverley, Peter M. A.
Link alla scheda completa:
Pubblicato in: